New Releases from NCBI BookshelfEffectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT.​Effectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT.

Parts of this abstract have been reproduced from  Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, et al.; TREAT Trial Investigators. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel-group assessor-blinded clinical trial. Br J Dermatol 2023;189:674–84. https://doi.org/10.1093/bjd/ljad281. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) licence, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The text below includes minor additions and formatting changes to the original text.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top